Emmanuel Velazquez-Alvarez: Bridging Innovation and Clinical Practice
Emmanuel Velazquez-Alvarez, Product Manager at Technoclone, shared a post on LinkedIn:
“Diagnostics is indeed a very dynamic area, with significant advances in automation, assay sensitivity, and data integration.
From my perspective, one of the main challenges remains translating technological innovation into routine clinical workflows.
Factors such as standardization across laboratories, regulatory requirements, cost effectiveness, and clinician familiarity can often slow adoption despite clear technical benefits.
Bridging that gap while maintaining diagnostic accuracy and supporting faster clinical decisions will continue to be a key focus for the field.
It was inspiring to meet and exchange ideas with colleagues, researchers, clinicians, and leading experts from around the world who are shaping the future of thrombosis, hemostasis, and healthcare innovation.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Sep 2, 2026, 15:09Kim Cook: Bringing Rare Blood Cancers Into the Conversation
-
Sep 2, 2026, 15:08Anupriya Ak: Blood Groups and Transfusion Compatibility
-
Sep 2, 2026, 14:51Amir Hesam Karbakhsh: The Science Behind Platelet-Rich Plasma Preparation
-
Sep 2, 2026, 14:38Brandi Littles Kelly: Raising ITP Awareness Through a Family’s Journey
-
Sep 2, 2026, 14:36Sangita Saha: Hemolysis in Hemodialysis – Causes, Prevention, Patient Safety
-
Sep 2, 2026, 14:31David Smadja: A New School Year, A Stronger Hematology Team
-
Sep 2, 2026, 14:28Khaled Musallam: The 5th MENA Congress for Rare Diseases Is Coming to Abu Dhabi
-
Sep 2, 2026, 14:21Christopher C. Young: MMA Embolization Shows Promise for Cancer Patients With Chronic Subdural Hematoma
-
Sep 2, 2026, 14:07Faheema Hasan: A New Second-Line Therapy for Essential Thrombocythemia